APOE4 Gene Mutation Test from Fenix Health Science

The page documents APOE genotyping with APOE4 copy-number reporting (0, 1, or 2 copies) from a cheek swab, processed in a CLIA- and CAP-certified laboratory that the company says analyzes over 800,000 genetic variants. The specific assay method and sensitivity or specificity figures are not published.

APOE4 copy number is the most informative framing of APOE-related Alzheimer's risk, and the product is explicitly positioned around it. The broader variant analysis supports the optional cognition reports, keeping the core offering tightly aligned with Alzheimer's genetic risk.

The basic $124.99 purchase covers APOE genotype and APOE4 copy number only. The Cognition+ upgrade with 13 reports and 59 genetic insights is a separate paid purchase whose price is not shown, so the advertised breadth is not included in the base test.

The basic test is clearly priced at $124.99 with no membership required. The Cognition+ upgrade price is not shown on the product page, so the full cost of the broader offering cannot be determined before purchase.

Results come with consumer-friendly interpretations and recommendations, and the page advises consulting a licensed genetic counselor. The copy-number result (0, 1, or 2 copies of APOE4) gives a clearer risk picture than a simple positive or negative.

The page carries an FDA disclaimer, details the kit contents and process, and states lab certifications. Turnaround is stated inconsistently - 2 to 3 weeks in the main copy versus 3 to 4 weeks in an FAQ section - and the upgrade price is not disclosed.

The at-home cheek-swab kit ships to the customer and returns via a prepaid mailer, with results by email. The conflicting turnaround statements mean delivery timing is recorded as a 14 to 28 day range.

The company states HIPAA and GDPR compliance, stores genetic data separately from personal identifiers, does not sell or share genetic data for advertising, and deletes data when consent is withdrawn - a complete and clearly stated privacy posture.